Evidence map›Paper›PMID 35349718›Full record

ArticleNucleic acids research2022

CRISPR-Cas9 gRNA efficiency prediction: an overview of predictive tools and the role of deep learning.

Vasileios Konstantakos, Anastasios Nentidis, Anastasia Krithara, Georgios Paliouras

Abstract read
In one paragraph

Article in Nucleic acids research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. 10 years of CRISPR/CAS genomic engineering in Yarrowia lipolytica.Bioprocess and biosystems engineering · 2026
    Review
  12. Article
  13. Arrayed dual-gRNA CRISPR screening platform forMolecular therapy. Advances · 2026
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. PALINCODE: Recording cell lineage with ternary palindromic CRISPR bits.bioRxiv : the preprint server for biology · 2026
    Article
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vasileios KonstantakosInstitute of Informatics and Telecommunications, NCSR Demokritos, Patr. Gregoriou E & 27 Neapoleos Str, 15341 Athens, Greece.ORCID 0000-0002-0332-7506
Anastasios NentidisInstitute of Informatics and Telecommunications, NCSR Demokritos, Patr. Gregoriou E & 27 Neapoleos Str, 15341 Athens, Greece.
Anastasia KritharaInstitute of Informatics and Telecommunications, NCSR Demokritos, Patr. Gregoriou E & 27 Neapoleos Str, 15341 Athens, Greece.
Georgios PaliourasInstitute of Informatics and Telecommunications, NCSR Demokritos, Patr. Gregoriou E & 27 Neapoleos Str, 15341 Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) system has become a successful and promising technology for gene-editing. To facilitate its effective application, various computational tools have been developed. These tools can assist researchers in the guide RNA (gRNA) design process by predicting cleavage efficiency and specificity and excluding undesirable targets. However, while many tools are available, assessment of their application scenarios and performance benchmarks are limited. Moreover, new deep learning tools have been explored lately for gRNA efficiency prediction, but have not been systematically evaluated. Here, we discuss the approaches that pertain to the on-target activity problem, focusing mainly on the features and computational methods they utilize. Furthermore, we evaluate these tools on independent datasets and give some suggestions for their usage. We conclude with some challenges and perspectives about future directions for CRISPR-Cas9 guide design.

Indexed as

Deep LearningGene EditingRNA, Guide, CRISPR-Cas SystemsCRISPR-Cas SystemsRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID35349718
PMCPMC9023298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.